Home/Filings/4/0001415889-24-010177
4//SEC Filing

Auster Martin 4

Accession 0001415889-24-010177

CIK 0001851194other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 7:30 PM ET

Size

5.3 KB

Accession

0001415889-24-010177

Insider Transaction Report

Form 4
Period: 2024-04-02
Auster Martin
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-04-02$5.40/sh1,405$7,59224,303 total
Footnotes (2)
  • [F1]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Represents the weighted average share price of an aggregate total of 1,405 shares sold in the price range of $5.28 to $5.4062. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Ventyx Biosciences, Inc.

CIK 0001851194

Entity typeother

Related Parties

1
  • filerCIK 0001875786

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:30 PM ET
Size
5.3 KB